Foamix Pharmaceuticals Ltd. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Foamix Pharmaceuticals Ltd. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$20.78 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-08-08
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-06-30 | -$20.78M 6-K · filed 2017-08-08 | |
| 2016-12-31 | -$27.37M 20-F · filed 2017-02-21 | |
| 2016-06-30 | -$12.11M 6-K · filed 2017-08-08 | |
| 2015-12-31 | -$12.50M 20-F · filed 2017-02-21 | |
| 2015-06-30 | -$5.78M 6-K · filed 2016-08-10 | |
| 2014-12-31 | -$714.00K 20-F · filed 2017-02-21 | |
| 2014-06-30 | $570.00K 6-K · filed 2015-10-19 | |
| 2013-12-31 | $228.00K 20-F · filed 2016-03-02 | |
| 2012-12-31 | -$2.39M 20-F · filed 2015-03-17 |